Clinics I work with
My reviews
4.9
Dr. Shah was excellent. Very friendly with an endearing personality and very knowledgeable about my cancer treatment and ongoing research. and gave me plenty of time.
Selected research
-
Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma.
Leukemia & lymphoma
-
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.
British journal of haematology
-
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Cancer
Clinical trials
Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refract...
ORR is defined as stringent complete response (sCR) + complete response (CR) + very good partial response + partial response (PR) as best response using International Myeloma Working Group (IMWG) Uniform Response Criteria for all ...
Recruiting